The Lancet Healthy Longevity in conversation with

Dr Sophie Vieujean on older adults with IBD and clinical trials

The Lancet Healthy Longevity

Dr Sophie Vieujean (Liège University Hospital) joins Ben Burwood to discuss her Review detailing the issues facing the inclusion of older adults with inflammatory bowel disease in clinical trials. 

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv